Prevalence of FID and QoL in Patients With Oncological and With Haematological Malignancies

Functional Iron Deficiency Clinical Trial

Official title:
Prevalence of Functional Iron Deficiency (FID) and Quality of Life (QoL) in Patients With Oncological and With Haematological Malignancies

Status Recruiting

Clinical Trial Summary

Prospective single-center observational study assessing prevalence of FID (Laboratory work-up) and Quality of Life (Questionnaire) in adult patients with oncological and with haematological malignancies within four weeks prior to disease-directed therapy.

Clinical Trial Description

Patients included into the study will have a laboratory work-up assessing the occurence of functional iron deficiency using laboratory parameters (full blood count, reticulocytes, transferrin saturation, serum-ferritin, CRP, ALAT) and have to fill in once the FACT-An questionnaire generating data on Quality of Life at time of study entry. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05333913
Study type	Observational
Source	Luzerner Kantonsspital
Contact	Axel Rüfer, MD
Phone	0041412055147
Email	axel.ruefer@luks.ch
Status	Recruiting
Phase
Start date	February 7, 2022
Completion date	July 31, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00495781` - Out Come Study To Define Laboratory Parameters That Are Best Suited to Diagnose Functional Iron Deficiency	N/A
Completed	`NCT01126905` - Mean Reticulated Haemoglobin (Hb) Content (RetHe) Analysis of Renal Patients
Withdrawn	`NCT02047552` - RCT of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients, With and Without Oxandrolone	Phase 2
Withdrawn	`NCT02009943` - Randomized Study Comparing Ferric Carboxymaltose to Iron Sucrose to Treat Fe Deficiency in the Surgically Critically Ill	Phase 1